Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

This study has been completed.

Sponsor:

Collaborator:

Elan Pharmaceuticals

Information provided by:

Biogen Idec

ClinicalTrials.gov Identifier:

NCT00027300

First received: November 30, 2001

Last updated: June 15, 2009

Last verified: June 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Primary Completion Date:	November 2004 (Final data collection date for primary outcome measure)

Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):